Modulatory Effect of the SLC9A3 Gene on Susceptibility to Infections and Pulmonary Function in Children With Cystic Fibrosis

被引:37
作者
Dorfman, Ruslan [7 ]
Taylor, Chelsea
Lin, Fan [7 ]
Sun, Lei [5 ,6 ]
Sandford, Andrew [4 ]
Pare, Peter [4 ]
Berthiaume, Yves [3 ]
Corey, Mary [6 ]
Durie, Peter [1 ,2 ]
Zielenski, Julian [7 ]
机构
[1] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Pediat, Toronto, ON, Canada
[3] Ctr Hosp Univ Montreal, Ctr Rech, Dept Med, Montreal, PQ, Canada
[4] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V5Z 1M9, Canada
[5] Univ Toronto, Dept Stat, Toronto, ON, Canada
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[7] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada
基金
加拿大健康研究院;
关键词
cystic fibrosis; lung disease; Pseudomonas aeruginosa; infection onset; pulmonary function; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE POLYMORPHISM ANALYSIS; LUNG-DISEASE; BICARBONATE SECRETION; CL-/HCO3-EXCHANGE; NHE3; INHIBITOR; CFTR; EXPRESSION; SEVERITY; SURFACE;
D O I
10.1002/ppul.21372
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In cystic fibrosis (CF), CFTR dysfunction leads to salt and water imbalance across airway epithelia, depleted surface liquid layer, and impaired mucociliary clearance. This provides optimal conditions for chronic bacterial infections leading to excessive inflammation and progressive obstructive lung disease. We hypothesized that other epithelial channels affecting salt balance across the airways may play a role in the susceptibility to bacterial infections and modulate severity of CF lung disease. The SLC9A3 gene encoding a Na+/H+ exchanger was demonstrated to be a modifier intestinal disease in a murine model of CF. We examined the potential role of SLC9A3 as a modifier of CF lung disease severity. We analyzed 11 SLC9A3 gene variants for association with age of first Pseudomonas aeruginosa infection and lung function in children with CF. The Tallele of an intronic variant in the SLC9A3 gene (rs4957061) was significantly (P = 0.02) associated with earlier acquisition of Pseudomonas infection in a cohort of 1,004 pediatric patients. Analysis of lung function in a subset of these patients (752) revealed that patients homozygous for the T allele had substantially reduced lung function and accelerated rate of decline. Although the functional basis for the modulatory effects of this SLC9A3 variant on CF lung disease remains to be elucidated, altered function of the Na+/H+ exchanger may further deplete the airway liquid surface, thereby enhancing susceptibility to Pseudomonas infections and worsening the severity of lung disease. Pediatr Pulmonol. 2011; 46: 385-392. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 36 条
[1]   Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas [J].
Ahmed, N ;
Corey, M ;
Forstner, G ;
Zielenski, J ;
Tsui, LC ;
Ellis, L ;
Tullis, E ;
Durie, P .
GUT, 2003, 52 (08) :1159-1164
[2]   Reciprocal protein kinase A regulatory interactions between cystic fibrosis transmembrane conductance regulator and Na+/H+ exchanger isoform 3 in a renal polarized epithelial cell model [J].
Bagorda, A ;
Guerra, L ;
Di Sole, F ;
Hemle-Kolb, C ;
Cardone, RA ;
Fanelli, T ;
Reshkin, SJ ;
Gisler, SM ;
Murer, H ;
Casavola, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21480-21488
[3]   Cystic fibrosis: a disease of vulnerability to airway surface dehydration [J].
Boucher, Richard C. .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (06) :231-240
[4]   Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice [J].
Bradford, Emily M. ;
Sartor, Maureen A. ;
Gawenis, Lara R. ;
Clarke, Lane L. ;
Shull, Gary E. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (04) :G886-G898
[5]   Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist:: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis [J].
Deterding, R ;
Retsch-Bogart, G ;
Milgram, L ;
Gibson, R ;
Daines, C ;
Zeitlin, PL ;
Milla, C ;
Marshall, B ;
LaVange, L ;
Engels, J ;
Mathews, D ;
Gorden, J ;
Schaberg, A ;
Williams, J ;
Ramsey, B .
PEDIATRIC PULMONOLOGY, 2005, 39 (04) :339-348
[6]   Mucus clearance and lung function in cystic fibrosis with hypertonic saline [J].
Donaldson, SH ;
Bennett, WD ;
Zeman, KL ;
Knowles, MR ;
Tarran, R ;
Boucher, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03) :241-250
[7]  
Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI33754, 10.1172/JCI337S4]
[8]   Genetic modifiers of lung disease in cystic fibrosis [J].
Drumm, ML ;
Konstan, MW ;
Schluchter, MD ;
Handler, A ;
Pace, R ;
Zou, F ;
Zariwala, M ;
Fargo, D ;
Xu, AR ;
Dunn, JM ;
Darrah, RJ ;
Dorfman, R ;
Sandford, AJ ;
Corey, M ;
Zielenski, J ;
Durie, P ;
Goddard, K ;
Yankaskas, JR ;
Wright, FA ;
Knowles, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (14) :1443-1453
[9]   NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions [J].
Favia, M. ;
Fanelli, T. ;
Bagorda, A. ;
Di Sole, F. ;
Reshkin, S. J. ;
Suh, P. G. ;
Guerra, L. ;
Casavola, V. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (02) :452-459
[10]   NHE3 inhibition activates duodenal bicarbonate secretion in the rat [J].
Furukawa, O ;
Bi, LC ;
Guth, PH ;
Engel, E ;
Hirokawa, M ;
Kaunitz, JD .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (01) :G102-G109